Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : IPHA save search
Innate Pharma 2023 Financial Calendar Innate Pharma SA released its 2023 financial calendar. argenx to Report Third Quarter 2022 Financial Results and Business Update on October 27, 2022 argenx announc...
Published: 2022-10-20 (Crawled : 07:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.35%
H: 1.28%
C: -0.17%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.19%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.0%
H: 2.4%
C: 1.92%
DNLI | $15.98 -3.74% -3.88% 1.5M
|
Health Technology
|
| O: -5.24%
H: 10.87%
C: 5.45%
pharma report financial update results
Innate Pharma Virtual 2021 Annual General Meeting
Published: 2021-05-12 (Crawled : 06:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.73%
H: 1.3%
C: 1.11%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.46%
H: 0.95%
C: 0.12%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -3.41%
H: 6.59%
C: 2.78%
pharma
Innate Pharma to return US and EU Lumoxiti commercialization rights to AstraZeneca
Published: 2020-12-11 (Crawled : 06:01) - globenewswire.com
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -19.59%
H: 6.5%
C: 1.16%
commercialization pharma
Innate Pharma to Host Key Opinion Leader Discussion on the Potential Role of Lacutamab Across T-Cell Lymphomas
Published: 2021-02-03 (Crawled : 06:00) - globenewswire.com
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 2.89%
H: 3.98%
C: 3.28%
t-cell potential pharma
NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF JULY 1, 2021
Published: 2021-07-12 (Crawled : 06:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.22%
H: 0.4%
C: -0.24%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.84%
H: 0.27%
C: -0.38%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.0%
H: 3.63%
C: 1.51%
pharma
New Lacutamab Data From Tellomak Trial to be Showcased in Oral Presentation at Upcoming 16th International Conference on Malignant LymphomaFirst clinical data of mycosis fungoides presented from the TELLOMAK trial
Published: 2021-06-09 (Crawled : 11:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.01%
H: 0.57%
C: 0.46%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.88%
H: 0.74%
C: 0.5%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.52%
H: 2.47%
C: -0.26%
presentation trial conference
New Lacutamab Data From Tellomak Trial to be Showcased in Oral Presentation at Upcoming 16th International Conference on Malignant Lymphoma
Published: 2021-06-09 (Crawled : 11:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.01%
H: 0.57%
C: 0.46%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.88%
H: 0.74%
C: 0.5%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.52%
H: 2.47%
C: -0.26%
presentation trial conference
Innate Pharma 2021 Financial Calendar
Published: 2020-12-02 (Crawled : 06:00) - globenewswire.com
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -3.82%
H: 2.46%
C: -2.46%
pharma
Innate Pharma to Participate in Upcoming Investor Conferences - November 02, 2022
Published: 2022-11-02 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.21%
H: 0.0%
C: -0.14%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 4.84%
H: 4.18%
C: 1.48%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.07%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -5.48%
H: 2.42%
C: -0.97%
pharma
Innate Pharma: First Patient Dosed in Monalizumab Phase 3 Lung Cancer Clinical Trial Triggers $50M Payment From AstraZeneca
Published: 2022-04-29 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.48%
H: 0.24%
C: 0.24%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 5.98%
H: 1.44%
C: -0.42%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.93%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 11.11%
H: 3.67%
C: -4.33%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.53%
H: 2.37%
C: 0.26%
trial payment cancer phase 3
Innate Pharma to participate in upcoming investor conferences
Published: 2021-01-04 (Crawled : 06:00) - globenewswire.com
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 3.42%
H: 2.36%
C: 1.89%
conference pharma
Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patients With Severe Pneumonia
Published: 2021-07-06 (Crawled : 06:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.54%
H: 0.03%
C: -0.23%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.0%
H: 0.1%
C: -0.25%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -3.41%
H: 2.32%
C: -0.59%
covid phase 2 trial covid-19
Innate Pharma Announces HSR Clearance Regarding Expansion of Its Collaboration With Sanofi on NK Cell Engagers
Published: 2023-01-25 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.92%
H: 1.41%
C: 1.41%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.97%
H: 1.74%
C: 1.28%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.39%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -0.28%
H: 1.66%
C: -0.28%
clearance expansion pharma collaboration sanofi
Innate Pharma Announces Conference Call and Webcast for First Half 2022 Business Update
Published: 2022-09-08 (Crawled : 06:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.65%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.72%
H: 1.61%
C: 1.55%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.47%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 1.54%
H: 0.76%
C: -1.52%
pharma conference update
Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 2021 Annual Meeting
Published: 2021-06-10 (Crawled : 06:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.31%
H: 1.42%
C: 1.21%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.21%
H: 1.07%
C: 0.67%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 2.87%
H: 5.33%
C: 4.82%
pharma
Innate Pharma to Participate in Upcoming Investor Conference - June 23, 2022
Published: 2022-06-23 (Crawled : 07:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.32%
H: 1.34%
C: 1.31%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.85%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 1.15%
H: 3.02%
C: -1.13%
pharma conference
Innate Pharma to present additional efficacy data for monalizumab in combination with cetuximab in head and neck cancer at the ESMO immuno-oncology virtual congress
Published: 2020-12-03 (Crawled : 14:02) - globenewswire.com
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 7.17%
H: 1.27%
C: -3.8%
cancer
Innate Pharma to Present Additional Efficacy Data for Monalizumab in Combination With Cetuximab in Head and Neck Cancer at the ESMO Immuno-Oncology Virtual CongressPhase 2 expansion cohort data supports ongoing Phase 3 trial
Published: 2020-12-03 (Crawled : 15:00) - biospace.com/
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 7.17%
H: 1.27%
C: -3.8%
cancer phase 3 trial expansion ongoing
Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 20, 2022
Published: 2022-04-08 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.75%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.49%
H: 1.22%
C: 0.47%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 3.55%
H: 0.0%
C: -1.87%
pharma
Innate Pharma announces conference call and webcast for Full Year 2020 financial results
Published: 2021-03-16 (Crawled : 06:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.0%
H: 0.96%
C: 0.78%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.27%
H: 1.17%
C: 1.15%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.0%
H: 1.06%
C: 0.85%
financial results results conference pharma
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.